Although insulin sensitizers such as metformin have long been used to treat PCOS metabolic dysfunction, newer medicines such as incretin mimetics and SGLT2 inhibitors have proven to be more effective at reducing weight and cardiovascular risk. This evidence concerns the gene INS and polycystic ovary syndrome.